Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kabashima

Showing results (341-350 of 1,269) with videos related to

Pageof 127
Sort By:
Frontiers in Immunology|July 19, 2019
An Update on the Role of Adipose Tissues in PsoriasisYisheng Wong, Satoshi Nakamizo, Kahbing J Tan, et al.
Cellular Immunology|May 30, 2018
Intravital imaging of cutaneous immune responsesSatoshi Nakamizo, Gyohei Egawa, Kahbing Jasmine Tan, et al.
Journal of Biochemistry|August 2, 2000
Glutamate 83 is important for stabilization of domain-domain conformation of Thermus aquaticus glycerol kinaseH S Huang, K Ito, T Kabashima, et al.
Archives of Dermatology|March 19, 2008
"Nagashima-type" keratosis as a novel entity in the palmoplantar keratoderma categoryKenji Kabashima, Jun-Ichi Sakabe, Yoko Yamada, et al.
The Journal of Investigative Dermatology|February 11, 2010
KIT masters mast cells in kids, tooNaotomo Kambe, B Jack Longley, Yoshiki Miyachi, et al.
Pharmacology & Therapeutics|March 4, 2021
Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trialsXiaoliang Yang, Naotomo Kambe, Riko Takimoto-Ito, et al.
The Journal of Investigative Dermatology|November 21, 2021
A New Era with the Development of Cytokine-Based Therapy for PruritusRintaro Shibuya, Riko Takimoto-Ito, Naotomo Kambe, et al.
Clinical and Experimental Immunology|January 16, 2024
PNAd-expressing vessels characterize the dermis of CD3+ T-cell-mediated cutaneous diseasesFatimah Mohammad Budair, Takashi Nomura, Masahiro Hirata, et al.
Archives of Dermatology|June 23, 2010
A case of intravascular large B-cell lymphoma with atypical clinical manifestations and analysis of CXCL12 and CXCR4 expressionSaeko Nakajima, Kouichi Ohshima, Masahisa Kyogoku, et al.
The British Journal of Dermatology|November 3, 2010
An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitisA Otsuka, T Honda, H Doi, et al.
Pageof 127

Showing results (341-350 of 1,269) with videos related to

Sort By:
Pageof 127
Frontiers in Immunology|July 19, 2019
An Update on the Role of Adipose Tissues in PsoriasisYisheng Wong, Satoshi Nakamizo, Kahbing J Tan, et al.
Cellular Immunology|May 30, 2018
Intravital imaging of cutaneous immune responsesSatoshi Nakamizo, Gyohei Egawa, Kahbing Jasmine Tan, et al.
Journal of Biochemistry|August 2, 2000
Glutamate 83 is important for stabilization of domain-domain conformation of Thermus aquaticus glycerol kinaseH S Huang, K Ito, T Kabashima, et al.
Archives of Dermatology|March 19, 2008
"Nagashima-type" keratosis as a novel entity in the palmoplantar keratoderma categoryKenji Kabashima, Jun-Ichi Sakabe, Yoko Yamada, et al.
The Journal of Investigative Dermatology|February 11, 2010
KIT masters mast cells in kids, tooNaotomo Kambe, B Jack Longley, Yoshiki Miyachi, et al.
Pharmacology & Therapeutics|March 4, 2021
Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trialsXiaoliang Yang, Naotomo Kambe, Riko Takimoto-Ito, et al.
The Journal of Investigative Dermatology|November 21, 2021
A New Era with the Development of Cytokine-Based Therapy for PruritusRintaro Shibuya, Riko Takimoto-Ito, Naotomo Kambe, et al.
Clinical and Experimental Immunology|January 16, 2024
PNAd-expressing vessels characterize the dermis of CD3+ T-cell-mediated cutaneous diseasesFatimah Mohammad Budair, Takashi Nomura, Masahiro Hirata, et al.
Archives of Dermatology|June 23, 2010
A case of intravascular large B-cell lymphoma with atypical clinical manifestations and analysis of CXCL12 and CXCR4 expressionSaeko Nakajima, Kouichi Ohshima, Masahisa Kyogoku, et al.
The British Journal of Dermatology|November 3, 2010
An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitisA Otsuka, T Honda, H Doi, et al.
Pageof 127